|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1281241609 |
| 003 |
OCoLC |
| 005 |
20231120010612.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
211030t20222022enk ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d GZM
|d OPELS
|d OCLCF
|d N$T
|d TXM
|d OCLCO
|d OCLCQ
|d TFW
|d K6U
|d SFB
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1281141122
|a 1281587989
|
| 020 |
|
|
|a 9780128142097
|q (electronic bk.)
|
| 020 |
|
|
|a 012814209X
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128142080
|
| 035 |
|
|
|a (OCoLC)1281241609
|z (OCoLC)1281141122
|z (OCoLC)1281587989
|
| 050 |
|
4 |
|a QH671
|
| 082 |
0 |
4 |
|a 571.9/36
|2 23
|
| 245 |
0 |
0 |
|a Mechanisms of cell death and opportunities for therapeutic development /
|c edited by Daiqing Liao.
|
| 264 |
|
1 |
|a London, United Kingdom ;
|a San Diego, CA, United States ;
|a Cambridge, MA, United States ;
|a Kidlington, Oxford, United Kingdom :
|b Elsevier, Academic Press, an Imprint of Elsevier,
|c [2022]
|
| 264 |
|
4 |
|c �2022
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Perspectives in translational cell biology
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Apoptosis, necroptosis, and pyroptosis in health and disease: an overview of molecular mechanisms, targets for therapeutic development, and known small molecule and biologic modulators -- Cell death: machinery and regulation -- Molecular mechanisms of cell death: a brief overview -- Major methods and technologies for assessing cell death -- Proteotoxicity and endoplasmic reticulum stress-mediated cell death -- Protein phase separation in cell death and survival -- Therapeutics targeting BCL2 family proteins -- Ferroptosis: lipids, iron, cellular defense mechanisms and opportunities for drug development.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect platform, viewed May 16, 2022).
|
| 650 |
|
0 |
|a Cell death.
|
| 650 |
|
0 |
|a Apoptosis.
|
| 650 |
|
0 |
|a Therapeutics.
|
| 650 |
|
2 |
|a Cell Death
|0 (DNLM)D016923
|
| 650 |
|
2 |
|a Apoptosis
|0 (DNLM)D017209
|
| 650 |
|
2 |
|a Therapeutics
|0 (DNLM)D013812
|
| 650 |
|
6 |
|a Cellules
|x Mort.
|0 (CaQQLa)201-0110794
|
| 650 |
|
6 |
|a Apoptose.
|0 (CaQQLa)201-0222225
|
| 650 |
|
6 |
|a Th�erapeutique.
|0 (CaQQLa)201-0009945
|
| 650 |
|
7 |
|a treating (health care function)
|2 aat
|0 (CStmoGRI)aat300137621
|
| 650 |
|
7 |
|a Cell death
|2 fast
|0 (OCoLC)fst00850180
|
| 700 |
1 |
|
|a Liao, Diaqing,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 0128142081
|z 9780128142080
|w (OCoLC)1082239443
|
| 830 |
|
0 |
|a Perspectives on translational cell biology series.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128142080
|z Texto completo
|
